There are thousands of drugs that silence many thousands of cancer-causing genetic abnormalities.
Some of these drugs are in use now, but many of these drugs are sitting on shelves or could be used beyond the disease for which they were originally approved. Repurposing these drugs depends on matching drugs to targets. A study recently published in the journal Bioinformatics describes a new database and pattern-matching algorithm that allows researchers to evaluate rational drugs and drug combinations, and also recommends a new drug combination to treat drug-resistant non-small cell lung cancer.
Read more . . .
The Latest on: Matching drugs to targets
[google_news title=”” keyword=”Matching drugs to targets” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Matching drugs to targets
- ‘The bane of retail.’ To prevent theft, many big chains now lock up all kinds of merchandiseon April 26, 2024 at 1:50 pm
David Johnston, vice president of asset protection and retail operations at the National Retail Federation, said that locking up more merchandise is “an unfortunate necessity” to combat theft and what ...
- A Closed-Loop Drug-Delivery System Could Improve Chemotherapyon April 25, 2024 at 3:19 pm
New CLAUDIA system could continuously monitor patients during an infusion, adjust dosage to maintain optimal drug levels ...
- Brit patient, 59, was ‘at death’s door’ – before experimental cancer drug ‘eradicated’ disease in 6 monthson April 24, 2024 at 12:11 am
A MAN “at death’s door” after running out of treatment options for leukaemia became the second person in the world to be offered an experimental cancer drug that eradicated ...
- Novartis dials up 2024 sales outlook, preps for key expansions of 3 cancer drugson April 23, 2024 at 12:37 pm
Novartis has increased its full-year sales guidance after pulling off a strong first quarter, even though three meds missed analysts’ expectations ahead of their key expansion opportunities. | ...
- How Many More Ozempic-like Drugs Are In the Pipeline — Here’s What Researchers Are Working Onon April 20, 2024 at 11:00 am
A new family of drugs is changing the way scientists are thinking about obesity — and more uses are on the horizon ...
- Eight stock picks in AI, obesity drugs, e-commerce and other growth areas beyond the S&P 500on April 20, 2024 at 3:45 am
Nicole Kornitzer of Buffalo Funds explains how she invests in “secular growth trends that can last a number of years.” ...
- NIH Researchers Develop AI Tool with Potential to More Precisely Match Cancer Drugs to Patientson April 19, 2024 at 6:39 am
Proof-of-concept study analyzed a newer technology known as single-cell RNA sequencing.
- Experimental AI predicts whether cancer drugs will workon April 19, 2024 at 3:25 am
Researchers in the US have developed an artificial intelligence tool that can predict how a patient will respond to cancer treatment, bringing the concept of personalised therapy a step closer to ...
- Raids in Eastern Washington target Norteño prison gang and drug traffickingon April 18, 2024 at 5:38 pm
Federal, tribal and local agencies arrested more than 20 people in a crackdown on gang crime in raids Thursday morning across Eastern Washington. The raids targeted La Nuestra Familia, a Norteño ...
- Obesity-drug power couple Novo Nordisk and Eli Lilly still have room to run, analysts sayon April 12, 2024 at 6:20 am
The BMO analysts initiated coverage of Novo Nordisk’s American depositary receipts NVO, +0.38% Friday with a $163 price target, representing roughly 30% upside to Thursday’s closing price. On top of ...
via Bing News